A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer
This study highlights the crucial role of LLPS in colon cancer, LRRS can be used to predict the prognosis of colon cancer patients and aid in the identification of more effective immunotherapy strategies.
Authors
- Shan Jiang (ORCID: https://orcid.org/0000-0002-7733-4987)
- Zhidong Gao (ORCID: https://orcid.org/0000-0002-8415-7587)
- Yingjiang Ye (ORCID: https://orcid.org/0000-0002-7904-3163)
- Peipei Zhang (ORCID: https://orcid.org/0000-0003-1742-1680)
- Chao Wang (ORCID: https://orcid.org/0009-0001-3192-253X)
- Sen Hou (ORCID: https://orcid.org/0000-0001-9907-1914)
- Shuo Wang (ORCID: https://orcid.org/0000-0002-1380-5890)
Institutions
- Peking University (CN)
- National Health and Family Planning Commission (CN)
- Shandong Provincial Hospital (CN)
- Peking University People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1514613
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- National Natural Science Foundation of China